Daron Evans
CIK 1411726 · CFO · last filed 2026-07-07
Daron Evans is a CFO who has filed 71 SEC Form 4 insider transactions across 4 companies since 2008. The most recent filing shows the insider had shares withheld for taxes covering $15.3K of RZLT on Jul 7, 2026. Across all open-market trades the lifetime net is +$739.4K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $2.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.57M
4
71
$739.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RZLT | CFO | 418,400 | $4.69 | $1.96M | $664.7K | 19 | 2026-07-07 |
| NEPH | CEO Specialty Renal Products | 143,162 | $4.21 | $602.7K | $59.9K | 8 | 2021-06-01 |
| CAPRICOR THERAPEUTICS, INC. (NLTXW) Delisted | Chief Financial Officer | 13,352 | — | — | $0 | 4 | 2011-04-19 |
| CAPRICOR THERAPEUTICS, INC. (NLTX) Delisted | Chief Financial Officer | 67 | $13.96 | $935 | $14.7K | 9 | 2010-02-17 |
Recent Filings
71 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-07 | RZLT | Tax (F) | −3,062 | -$15.3K | EDGAR |
| 2026-03-04 | RZLT | Tax (F) | −11,438 | -$34.2K | EDGAR |
| 2025-12-15 | RZLT | Buy (P) | +45,000 | $79.6K | EDGAR |
| 2025-11-21 | RZLT | Grant (A) | +107,000 | $0 | EDGAR |
| 2025-06-24 | RZLT | Buy (P) | +5,000 | $20.2K | EDGAR |
| 2025-06-12 | RZLT | Grant (A) | +26,000 | $0 | EDGAR |
| 2025-03-28 | RZLT | Buy (P) | +20,000 | $57.7K | EDGAR |
| 2025-02-19 | RZLT | Grant (A) | +77,000 | $0 | EDGAR |
| 2024-12-18 | RZLT | Buy (P) | +10,000 | $42.9K | EDGAR |
| 2024-12-12 | RZLT | Buy (P) | +9,000 | $41.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.